Merck Second-Quarter Profit Beats Estimates on Diabetes Drugs

Merck Second-Quarter Profit Beats Estimates on Diabetes Drugs

JB Reed/Bloomberg

Merck has been cutting thousands of jobs and trying to boost demand of existing products to prepare for when Singulair faces cheaper copies in August.